- About
- Dean’s Office
- Research
- Education
- Patient Care
- People
- News
- Events
Janel Long-Boyle, PharmD
Associate Professor
What I do
I am a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of my research is focused around the chemotherapeutic and immunosuppressive agents used in the conditioning regimens of pediatric hematopoietic cell transplantation (HCT). Specifically, I am interested in how patient specific covariates such as age, renal function, or genetic variants involved in drug metabolism or distribution may influence drug clearance in the pediatric HCT population.
Departmental research area
My research expertise
pharmacokinetics, pharmacodynamics, pediatric pharmacology, pediatric hematology, oncology, bone marrow transplantation
Clinical expertise
hematology, oncology, bone marrow transplantation
Degrees
PhD, Experimental and Clinical Pharmacology, University of Minnesota, 2009
PharmD, University of Minnesota, 2006
BS, Biochemistry, University of Minnesota, 2000
Biography
Dr. Boyle is a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of her research resides within the complex setting of hematopoietic cell transplantation (HCT) and is focused around chemotherapeutic and immunosuppressive agents used in the preparative regimens of pediatric HCT. Specifically, Dr. Boyle studies how covariates such as age, renal function, or genetic variants involved in drug metabolism or distribution may influence drug clearance in the pediatric HCT population.
Research keywords
Oncology, Pharmacokinetics-Pharmacodynamics, Hematopoietic Cell Transplantation, Hematology, Pediatric Pharmacology, Mycophenolic Acid, Tandem Mass Spectrometry, Hematologic Neoplasms, Adenine Nucleotides, Arabinonucleosides, Hematopoietic Stem Cell Transplantation, Immunosuppressive Agents, Patient-Specific Modeling, Transplantation, Autologous, Transplantation Conditioning, Busulfan, Biological Models, Melphalan, Vidarabine, Antineoplastic Agents, Alkylating
Licensure and certifications
Licentiate in Pharmacy, Minnesota, 2006
Licentiate in Pharmacy, California, 2010